Creating a world free of ALS is our North Star. And we’re kicking off 2019 with over $1 million to fund research and clinical care at the Les Turner ALS Center! We’re excited to fund five novel research endeavors from some of our lead researchers at the Les Turner ALS Center through 2021, including two projects from Dr. Kiskinis’s lab. “These awards will allow us to expand our efforts to decipher the pathological mechanisms that give rise to this devastating disease,” says Dr. Kiskinis. “The Les Turner ALS Center at Northwestern Medicine provides us with an unparalleled community of researchers and clinicians with the common goal of defeating ALS.”
Dr. Kiskinis is eager for the new opportunities this funding will open in his research, “We are particularly focused on understanding how mutations in C9orf72, the largest genetic cause of ALS, and a newly discovered gene known as NEK1 impact the function of human neurons. I am delighted to receive this funding and grateful to the Les Turner ALS Foundation for their continued and generous support.”
New this year is our “Translating Research and Implementation for ALS” or TRIALS program. The goal of TRIALS is to increase the number of clinical trials being done at the Lois Insolia ALS Clinic and pave the way to quickly implement clinical and translational research being conducted at the Les Turner ALS Center.
We can’t think of a better way to start a brand new year! See our gifts to the Les Turner ALS Center at Northwestern Medicine.